<DOC>
	<DOCNO>NCT00830102</DOCNO>
	<brief_summary>The primary purpose evaluate efficacy SKP FlutiForm HFA MDI compare placebo fluticasone formoterol administer concurrently alone asthma patient .</brief_summary>
	<brief_title>Single-dose Crossover Study Compare Safety Efficacy FlutiForm With Fluticasone Formoterol Concurrently Alone Asthma Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Subjects document history mild moderate asthma currently take stable dose inhale corticosteroid Smoking history within last 12 month No history respiratory tract infection within 4 week No history evidence clinically significant disease abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Mild Moderate Asthma</keyword>
</DOC>